Factors associated with osteonecrosis in Thai lupus patients: a case control study
- PMID: 20009970
- DOI: 10.1097/RHU.0b013e3181ba3423
Factors associated with osteonecrosis in Thai lupus patients: a case control study
Abstract
Objective: To identify associated factors for the development of osteonecrosis of a femoral head (ON) in patients with systemic lupus erythematosus (SLE).
Methods: We conducted a retrospective nested case-control study from SLE patients who attended the Rheumatology Clinic at Phramongkutklao Hospital from 1992-2008. Cases were defined as SLE patients, who had clinically apparent ON (confirmed by plain radiographs or magnetic resonance imaging). For each case, a control was selected and matched to the case by age and disease duration. The main outcome measure was the odds ratio (OR) of ON among SLE patients. The clinical and laboratory variables thought to be risk factors of ON variables were compared between patients who did and did not develop ON. Significant and clinically relevant variables were then examined by a stepwise logistic regression model.
Results: Of 186 SLE patients, we identified 41 patients who developed ON during the course of follow-up. Twenty patients were available for data analysis. From the univariate analysis, incidence of renal involvement and the use of steroids (recorded as evidenced by maximum and mean daily prednisolone dose) were significantly higher in the ON group than in controls. The use of antimalarials was significantly lower in patients with ON than in controls. No difference in disease activity, lipid profiles or anticardiolipin antibody was found between groups. In the logistic regression, the presence of renal involvement remained as a positive associated factor for ON (OR = 7.80, CI = 1.249-48.748, P = 0.028) and the use of antimalarial drugs was a negative associated factor for ON (OR = 0.09, CI = 0.009-0.961, P = 0.046).
Conclusion: The presence of renal involvement was associated with ON and the antimalarial use may have a protective effect for ON in Thai patients with SLE. The findings from this study further support the use of antimalarial drugs in SLE patients.
Similar articles
-
The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus.Arthritis Rheum. 2010 Mar;62(3):863-8. doi: 10.1002/art.27289. Arthritis Rheum. 2010. PMID: 20131232
-
Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus.J Rheumatol. 2001 Apr;28(4):761-5. J Rheumatol. 2001. PMID: 11327247
-
Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus.Arthritis Rheum. 2006 Jul;54(7):2220-7. doi: 10.1002/art.21967. Arthritis Rheum. 2006. PMID: 16802358
-
'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.Rheumatology (Oxford). 2005 Dec;44(12):1492-502. doi: 10.1093/rheumatology/kei142. Epub 2005 Oct 18. Rheumatology (Oxford). 2005. PMID: 16234277 Review.
-
Aseptic necrosis and glucocorticosteroids in systemic lupus erythematosus: a reevaluation.J Rheumatol. 1989 May;16(5):604-8. J Rheumatol. 1989. PMID: 2666654 Review.
Cited by
-
The association of an elevated Th/Ts ratio and lupus anticoagulant with symptomatic osteonecrosis in systemic lupus erythematosus patients.Front Immunol. 2024 Feb 7;15:1288234. doi: 10.3389/fimmu.2024.1288234. eCollection 2024. Front Immunol. 2024. PMID: 38384449 Free PMC article.
-
Systemic lupus erythematosus patients with high disease activity are associated with accelerated incidence of osteonecrosis: a systematic review and meta-analysis.Clin Rheumatol. 2018 Jan;37(1):5-11. doi: 10.1007/s10067-017-3820-5. Epub 2017 Sep 25. Clin Rheumatol. 2018. PMID: 28948379
-
Associations between glucocorticoids, antiphospholipid antibodies and femur head necrosis in patients with SLE: a directed acyclic graph-based multicentre study.Ther Adv Musculoskelet Dis. 2021 Mar 29;13:1759720X211002677. doi: 10.1177/1759720X211002677. eCollection 2021. Ther Adv Musculoskelet Dis. 2021. PMID: 33854569 Free PMC article.
-
Osteonecrosis in systemic lupus erythematosus: an early, frequent, and not always symptomatic complication.Autoimmune Dis. 2012;2012:725249. doi: 10.1155/2012/725249. Epub 2012 Aug 5. Autoimmune Dis. 2012. PMID: 22919470 Free PMC article.
-
Steroid induced osteonecrosis: An analysis of steroid dosing risk.Autoimmun Rev. 2010 Sep;9(11):721-43. doi: 10.1016/j.autrev.2010.06.007. Epub 2010 Jul 9. Autoimmun Rev. 2010. PMID: 20621176 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous